The benefits of hormone replacement therapy (HRT) combining estrogen and progestin in treating some conditions like osteoporosis and Alzheimer’s disease may outweigh the risks, so the government will continue to study HRT in those conditions, National Institutes of Health officials said here Wednesday.
The National Heart, Lung and Blood Institute, National Institute on Aging, and the National Institute on Arthritis and Musculoskeletal Diseases, are continuing to analyze completed studies and funding ongoing trials of HRT to combat bone loss, memory loss, and cardiovascular disease, researchers said.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!